155 related articles for article (PubMed ID: 35797485)
21. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
23. Water soluble, multifunctional antibody-porphyrin gold nanoparticles for targeted photodynamic therapy.
Penon O; Marín MJ; Russell DA; Pérez-García L
J Colloid Interface Sci; 2017 Jun; 496():100-110. PubMed ID: 28214620
[TBL] [Abstract][Full Text] [Related]
24. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
[TBL] [Abstract][Full Text] [Related]
25. Recent Advances in Efficacy of using Doxorubicin Gold Nanoparticles for Chemo-, Radio-, Photothermal, and Photodynamic Therapy.
Choubdar N; Avizheh S; Karimifard SA
Curr Drug Deliv; 2022; 19(7):745-762. PubMed ID: 34238159
[TBL] [Abstract][Full Text] [Related]
26. A Redox-Activatable and Targeted Photosensitizing Agent to Deliver Doxorubicin for Combining Chemotherapy and Photodynamic Therapy.
Yin J; Ouyang C; Shen S; Zhou Y; He G; Zhang H; Zhou K; Chen G; Ren L
Mol Pharm; 2022 Jul; 19(7):2441-2455. PubMed ID: 35616274
[TBL] [Abstract][Full Text] [Related]
27. Photothermal versus photodynamic treatment for the inactivation of the bacteria Escherichia coli and Bacillus cereus: An in vitro study.
ElZorkany HE; Youssef T; Mohamed MB; Amin RM
Photodiagnosis Photodyn Ther; 2019 Sep; 27():317-326. PubMed ID: 31252144
[TBL] [Abstract][Full Text] [Related]
28. Water-Soluble, Zwitterionic Poly-photosensitizers as Carrier-Free, Photosensitizer-Self-Delivery System for in Vivo Photodynamic Therapy.
Zheng N; Xie D; Wang C; Zhang Z; Zheng Y; Lu Q; Bai Y; Li Y; Wang A; Song W
ACS Appl Mater Interfaces; 2019 Nov; 11(47):44007-44017. PubMed ID: 31696699
[TBL] [Abstract][Full Text] [Related]
29. Photo-induced reactions for disassembling of coloaded photosensitizer and drug molecules from upconversion-mesoporous silica nanoparticles: An effective synergistic cancer therapy.
Rafique R; Gul AR; Lee IG; Baek SH; Kailasa SK; Iqbal N; Cho EJ; Lee M; Park TJ
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110545. PubMed ID: 32204054
[TBL] [Abstract][Full Text] [Related]
30. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
31. Nanoscaled PAMAM Dendrimer Spacer Improved the Photothermal-Photodynamic Treatment Efficiency of Photosensitizer-Decorated Confeito-Like Gold Nanoparticles for Cancer Therapy.
Saw WS; Anasamy T; Do TTA; Lee HB; Chee CF; Isci U; Misran M; Dumoulin F; Chong WY; Kiew LV; Imae T; Chung LY
Macromol Biosci; 2022 Aug; 22(8):e2200130. PubMed ID: 35579182
[TBL] [Abstract][Full Text] [Related]
32. Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy.
Zheng K; Liu H; Liu X; Wang Y; Li L; Li S; Xue J; Huang M
Int J Nanomedicine; 2020; 15():151-167. PubMed ID: 32021171
[TBL] [Abstract][Full Text] [Related]
33. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy.
Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W
Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978
[TBL] [Abstract][Full Text] [Related]
34. pH/ROS dual stimuli-responsive anionic flexible supramolecular organic frameworks for synergistic therapy.
Yin Y; Gao L; Sun P; Zeng L; Zhao Q; Chen S; Liu J; Wang L
Acta Biomater; 2023 Dec; 172():395-406. PubMed ID: 37866724
[TBL] [Abstract][Full Text] [Related]
35. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
Shi J; Chen Z; Wang L; Wang B; Xu L; Hou L; Zhang Z
Acta Biomater; 2016 Jan; 29():282-297. PubMed ID: 26485168
[TBL] [Abstract][Full Text] [Related]
36. ROS-Responsive and active targeted drug delivery based on conjugated polymer nanoparticles for synergistic chemo-/photodynamic therapy.
Zhang Z; Lu Z; Yuan Q; Zhang C; Tang Y
J Mater Chem B; 2021 Mar; 9(9):2240-2248. PubMed ID: 33596297
[TBL] [Abstract][Full Text] [Related]
37. Stimuli-Sensitive Linear-Dendritic Block Copolymer-Drug Prodrug as a Nanoplatform for Tumor Combination Therapy.
Cai H; Tan P; Chen X; Kopytynski M; Pan D; Zheng X; Gu L; Gong Q; Tian X; Gu Z; Zhang H; Chen R; Luo K
Adv Mater; 2022 Feb; 34(8):e2108049. PubMed ID: 34875724
[TBL] [Abstract][Full Text] [Related]
38. Long circulating photoactivable nanomicelles with tumor localized activation and ROS triggered self-accelerating drug release for enhanced locoregional chemo-photodynamic therapy.
Uthaman S; Pillarisetti S; Mathew AP; Kim Y; Bae WK; Huh KM; Park IK
Biomaterials; 2020 Feb; 232():119702. PubMed ID: 31896514
[TBL] [Abstract][Full Text] [Related]
39. Folic acid-modified bovine serum albumin nanoparticles with doxorubicin and chlorin e6 for effective combinational chemo-photodynamic therapy.
Lee H; Kim S; Oh C; Khan I; Shukla S; Bajpai VK; Han YK; Huh YS
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111343. PubMed ID: 32919690
[TBL] [Abstract][Full Text] [Related]
40. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses.
Yang Y; Chen F; Xu N; Yao Q; Wang R; Xie X; Zhang F; He Y; Shao D; Dong WF; Fan J; Sun W; Peng X
Biomaterials; 2022 Feb; 281():121368. PubMed ID: 35030436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
